BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 30339972)

  • 1. The histologic, immunohistochemical, and genetic features of classical Hodgkin lymphoma and anaplastic large cell lymphoma with aberrant T-cell/B-cell antigen expression.
    Liang K; Wang J; Wang Y; Zhou Z; Ge S; Mei S; Li H; Jing X; Zhang C
    Hum Pathol; 2019 Feb; 84():309-320. PubMed ID: 30339972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRF8 as a Novel Marker to Differentiate Between CD30-Positive Large Cell Lymphomas.
    McQuaid DC; Katz SG; Xu ML
    Am J Clin Pathol; 2022 Aug; 158(2):173-176. PubMed ID: 35460405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry of ALK-negative anaplastic large cell lymphoma of breast implant-associated effusion and capsular tissue.
    Wu D; Allen CT; Fromm JR
    Cytometry B Clin Cytom; 2014 Jun; ():. PubMed ID: 24976005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin Lymphoma.
    Gomez F; Fisk B; McMichael JF; Mosior M; Foltz JA; Skidmore ZL; Duncavage EJ; Miller CA; Abel H; Li YS; Russler-Germain DA; Krysiak K; Watkins MP; Ramirez CA; Schmidt A; Martins Rodrigues F; Trani L; Khanna A; Wagner JA; Fulton RS; Fronick CC; O'Laughlin MD; Schappe T; Cashen AF; Mehta-Shah N; Kahl BS; Walker J; Bartlett NL; Griffith M; Fehniger TA; Griffith OL
    Cancer Res Commun; 2023 Nov; 3(11):2312-2330. PubMed ID: 37910143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma.
    van Bladel DAG; Stevens WBC; Kroeze LI; de Groen RAL; de Groot FA; van der Last-Kempkes JLM; Berendsen MR; Rijntjes J; Luijks JACW; Bonzheim I; van der Spek E; Plattel WJ; Pruijt JFM; de Jonge-Peeters SDPWM; Velders GA; Lensen C; van Bladel ER; Federmann B; Hoevenaars BM; Pastorczak A; van der Werff Ten Bosch J; Vermaat JSP; Nooijen PTGA; Hebeda KM; Fend F; Diepstra A; van Krieken JHJM; Groenen PJTA; van den Brand M; Scheijen B
    Blood Adv; 2023 Oct; 7(19):5911-5924. PubMed ID: 37552109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic Variants Associated with Epigenetic Control and the NOTCH Pathway Are Frequent in Classic Hodgkin Lymphoma.
    Santisteban-Espejo A; Bernal-Florindo I; Montero-Pavon P; Perez-Requena J; Atienza-Cuevas L; Fernandez-Valle MDC; Villalba-Fernandez A; Garcia-Rojo M
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined linkage and association analysis of classical Hodgkin lymphoma.
    Lawrie A; Han S; Sud A; Hosking F; Cezard T; Turner D; Clark C; Murray GI; Culligan DJ; Houlston RS; Vickers MA
    Oncotarget; 2018 Apr; 9(29):20377-20385. PubMed ID: 29755658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Aberrant CD58 Expression in a Wide Spectrum of Lymphoma Subtypes: Implications for Treatment Resistance.
    Younes S; Zhao S; Bharadwaj S; Mosquera AP; Libert D; Johnsrud A; Majzner RG; Miklos DB; Frank MJ; Natkunam Y
    Mod Pathol; 2023 Oct; 36(10):100256. PubMed ID: 37391168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokines, Genetic Lesions and Signaling Pathways in Anaplastic Large Cell Lymphomas.
    Merlio JP; Kadin ME
    Cancers (Basel); 2021 Aug; 13(17):. PubMed ID: 34503066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical characteristics and prognosis of pediatric relapsed/refractory anaplastic large cell lymphoma].
    Zhu LJ; Zhu J; Lu SY; Wang J; Sun FF; Huang JT; Que Y; Huang H; Huang HQ; Zhen ZZ; Sun XF; Zhang YZ
    Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):854-856. PubMed ID: 38049339
    [No Abstract]   [Full Text] [Related]  

  • 11. Transformation of CLL to ALCL: the role of clonality studies in diagnostic molecular haematopathology.
    Colling R; Royston D; Soilleux E
    J Hematop; 2016 Sep; 9(3):143-147. PubMed ID: 27766121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Johnston RL, Mottok A, Chan FC, et al. A gene expression-based model predicts outcome in children with intermediate-risk classical Hodgkin lymphoma. Blood. 2022;139(6):889-893.
    Blood; 2023 Mar; 141(12):1495. PubMed ID: 36951881
    [No Abstract]   [Full Text] [Related]  

  • 13. Blastoid and pleomorphic mantle cell lymphoma: still a diagnostic and therapeutic challenge!
    Dreyling M; Klapper W; Rule S
    Blood; 2018 Dec; 132(26):2722-2729. PubMed ID: 30385481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New concepts in follicular lymphoma biology: From BCL2 to epigenetic regulators and non-coding RNAs.
    Devan J; Janikova A; Mraz M
    Semin Oncol; 2018 Oct; 45(5-6):291-302. PubMed ID: 30360879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-resolution architecture and partner genes of
    Chong LC; Ben-Neriah S; Slack GW; Freeman C; Ennishi D; Mottok A; Collinge B; Abrisqueta P; Farinha P; Boyle M; Meissner B; Kridel R; Gerrie AS; Villa D; Savage KJ; Sehn LH; Siebert R; Morin RD; Gascoyne RD; Marra MA; Connors JM; Mungall AJ; Steidl C; Scott DW
    Blood Adv; 2018 Oct; 2(20):2755-2765. PubMed ID: 30348671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Spectrum of EBV-Positive Mucocutaneous Ulcer: A Study of 9 Cases.
    Prieto-Torres L; Eraña I; Gil-Redondo R; Gómez de la Riva I; Manso R; Pajares R; Córdoba R; Machan S; Ara M; Requena L; Piris MÁ; Rodríguez-Pinilla SM
    Am J Surg Pathol; 2019 Feb; 43(2):201-210. PubMed ID: 30418184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The translational science of hodgkin lymphoma.
    Cirillo M; Reinke S; Klapper W; Borchmann S
    Br J Haematol; 2019 Jan; 184(1):30-44. PubMed ID: 30417946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of Hodgkin lymphoma in the modern era.
    Wang HW; Balakrishna JP; Pittaluga S; Jaffe ES
    Br J Haematol; 2019 Jan; 184(1):45-59. PubMed ID: 30407610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RUNX1 Mutations Can Lead to Aberrant Expression of CD79a and PAX5 in Acute Myelogenous Leukemias: A Potential Diagnostic Pitfall.
    Menter T; Lundberg P; Wenzel F; Dirks J; Fernandez P; Friess D; Dirnhofer S; Tzankov A
    Pathobiology; 2019; 86(2-3):162-166. PubMed ID: 30396184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive B cell lymphomas in the 2017 revised WHO classification of tumors of hematopoietic and lymphoid tissues.
    Grimm KE; O'Malley DP
    Ann Diagn Pathol; 2019 Feb; 38():6-10. PubMed ID: 30380402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.